NASDAQ:ADTX Aditxt (ADTX) Stock Price, News & Analysis $0.0023 0.00 (-17.86%) As of 10/14/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsInsider TradesNews and TrendsSEC Filings About Aditxt Stock (NASDAQ:ADTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aditxt alerts:Sign Up Key Stats Today's Range$0.0021▼$0.002850-Day Range N/A52-Week Range$0.00▼$13,885.71Volume27.49 million shsAverage Volume89.89 million shsMarket Capitalization$1.88 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Aditxt, Inc. is a biotechnology company focused on developing and commercializing technologies designed to support immune monitoring and precision health. Its work centers on tools that can provide broader insight into an individual’s immune status, with potential applications in infectious diseases, vaccine response, autoimmune conditions, allergies and cancer. The company’s primary platform, AditxtScore, is designed to measure and monitor multiple immune-system markers from a single sample. Aditxt has described the platform as useful for tracking immune responses over time and supporting more personalized approaches to disease detection, prevention and treatment. The company has also pursued additional health-related opportunities through partnerships and acquisitions. Aditxt was founded in 2017 and is headquartered in Mountain View, California. The company’s operations and development efforts have been focused primarily on the United States, while its technologies are intended for potential use by healthcare providers, researchers and pharmaceutical companies in broader markets. Amro Albanna is a co-founder and has served as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Aditxt Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreADTX MarketRank™: 0.03816793893 of 5 starsAditxt scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingAditxt has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAditxt has received no research coverage in the past 90 days.Read more about Aditxt's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aditxt is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aditxt is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAditxt has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aditxt's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ADTX. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAditxt does not currently pay a dividend.Dividend GrowthAditxt does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest6 people have searched for ADTX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Aditxt to their MarketBeat watchlist in the last 30 days. This is a decrease of -77% compared to the previous 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aditxt insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of Aditxt is held by insiders.Percentage Held by Institutions15.54% of the stock of Aditxt is held by institutions.Read more about Aditxt's insider trading history. Receive ADTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aditxt and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADTX Stock News HeadlinesAditxt Faces Nasdaq Delisting, Moves Fully to OTCSeptember 23, 2026 | tipranks.comAditxt Divests Pearsanta Stake, Retains Royalty UpsideAugust 19, 2026 | tipranks.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | Investors Alley (Ad)Aditxt Stock Dividends | NASDAQ:ADTX | BenzingaJuly 13, 2026 | benzinga.comADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish?June 25, 2026 | finance.yahoo.comADTX Stock Surges 40% Overnight: New 10% Holder Emerges After Aditxt’s Ignite Proteomics SPAC DealJune 23, 2026 | msn.comAditxt Expands Secured Convertible Note Financing CapacityJune 23, 2026 | tipranks.comAditxt (ADTX) stock surges nearly 17% after hours: Here's whyJune 12, 2026 | msn.comSee More Headlines ADTX Stock Analysis - Frequently Asked Questions How have ADTX shares performed this year? Aditxt's stock was trading at $180.2520 at the start of the year. Since then, ADTX stock has decreased by 100.0% and is now trading at $0.0023. How were Aditxt's earnings last quarter? Aditxt, Inc. (NASDAQ:ADTX) announced its earnings results on Thursday, August, 14th. The company reported ($84,207.60) earnings per share (EPS) for the quarter. Aditxt had a negative trailing twelve-month return on equity of 374.60% and a negative net margin of 360,152.50%. When did Aditxt's stock split? Shares of Aditxt reverse split on the morning of Monday, May 18th 2026.The 1-27 reverse split was announced on Thursday, May 14th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 15th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Aditxt? Shares of ADTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aditxt own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aditxt investors own include Tesla (TSLA), NVIDIA (NVDA), NIO (NIO), Advanced Micro Devices (AMD), Bionano Genomics (BNGO), Intel (INTC) and MARA (MARA). Company Calendar Last Earnings8/14/2025Today10/14/2026Next Earnings (Estimated)12/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ADTX's financial health is in the Green zone, according to TradeSmith. ADTX has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ADTX CIK1726711 Webwww.aditxt.com Phone650-870-1200FaxN/AEmployees26Year Founded2017Profitability EPS (Trailing Twelve Months)($100,788.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$41.71 million Net Margins-360,152.50% Pretax Margin-367,584.03% Return on Equity-374.60% Return on Assets-105.93% Debt Debt-to-Equity RatioN/A Current Ratio0.06 Quick Ratio0.05 Sales & Book Value Annual Sales$14.34 thousand Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value$259.70 per share Price / Book0.00Miscellaneous Outstanding Shares816,000Free Float816,000Market Cap$1.88 thousand OptionableNo Data Beta1.34 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:ADTX) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
